Janssen Ad26.CoV2.S Vaccine Booster in Kidney Transplant Recipients

NCT05220397 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

468

Enrollment

OTHER

Sponsor class

Stopped Janssen Biotech, Inc stopped production of the vaccine, and it was no longer available as of 2023.

Conditions

Kidney Transplant Recipient

Interventions

BIOLOGICAL: Janssen Ad26.CoV2.S Vaccine
OTHER: Reduction in Immunosuppression Medication
OTHER: Maintenance in Immunosuppression Medication

Sponsor

Mark Stegall

Collaborators

[object Object]